13F Portfolios

Commodore Capital LP: TANGO THERAPEUTICS INC (TNGX): Quarterly 13F Position History

As of Q2 2026, Commodore Capital LP reported 2,250,000 shares of TANGO THERAPEUTICS INC (TNGX), worth $70.3M and representing 4.2% of its 13F equity book. Quarter-over-quarter share count change: + 2,250,000 (re-initiated) . The position first appeared in Q2 2025 and has been disclosed across 5 13F-HR filings in Pactolio's tracked window.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 5 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q2 2026 2,250,000 +2,250,000 $70.3M 4.2% $31.3
Q1 2026 0 0 $0 0.0%
Q4 2025 0 1,500,000 -100.0% $0 0.0%
Q3 2025 1,500,000 0 $12.6M 0.6% $8.4
Q2 2025 1,500,000 $7.7M 0.5% $5.1

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.

When did Commodore Capital LP first disclose a TNGX position in 13F-HR filings?

Commodore Capital LP first reported TANGO THERAPEUTICS INC (TNGX) on its 13F-HR filing for the period ending 2025-06-30 (Q2 2025). The position has appeared on 5 reported quarters within Pactolio's tracked window.

What was Commodore Capital LP's most recent quarter-over-quarter share-count change in TNGX?

Between Q1 2026 and Q2 2026, Commodore Capital LP added 2,250,000 shares of TNGX (re-initiated), bringing the total reported position to 2,250,000 shares at a market value of $70.3M.

Does the implied price-per-share represent Commodore Capital LP's cost basis in TNGX?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.